CompletedPhase 3NCT03079167
PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns
Studying Neonatal hypoxic and ischemic brain injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Sydney
- Principal Investigator
- Helen Liley, BHB, MBChBUniversity of Sydney
- Intervention
- Epoetin Alfa(drug)
- Enrollment
- 313 enrolled
- Eligibility
- All sexes
- Timeline
- 2016 – 2024
Study locations (24)
- Canberra Hospital, Garran, Australian Capital Territory, Australia
- Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
- Nepean Hospital, Kingswood, New South Wales, Australia
- John Hunter Hospital, New Lambton, New South Wales, Australia
- Royal Hospital for Women, Randwick, New South Wales, Australia
- Royal North Shore Hospital, St Leonards, New South Wales, Australia
- Westmead Hospital, Westmead, New South Wales, Australia
- Royal Women's & Brisbane Hospital, Herston, Queensland, Australia
- Mater Mothers' Hospital, South Brisbane, Queensland, Australia
- Flinders Medical Centre, Bedford Park, South Australia, Australia
- Women's and Children's Hospital, North Adelaide, South Australia, Australia
- Royal Hobart Hospital, Hobart, Tasmania, Australia
- Monash Medical Centre, Clayton, Victoria, Australia
- Mercy Hospital for Women, Heidelberg, Victoria, Australia
- The Royal Children's Hospital, Parkville, Victoria, Australia
- +9 more locations on ClinicalTrials.gov
Collaborators
National Health and Medical Research Council, Australia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03079167 on ClinicalTrials.govOther trials for Neonatal hypoxic and ischemic brain injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07464938New Tools and Predictive Markers in the Prognosis of Hypoxic-ischemic Encephalopathy Following Cardiac ArrestCliniques universitaires Saint-Luc- Université Catholique de Louvain
- ENROLLING BY INVITATIONNCT07264166Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)Healing Hope International
- RECRUITINGNCT07393620Predictive Value of aEEG and Cerebral Oxygenation on Neurological Outcomes in Newborns With Mild Hypoxic-Ischemic EncephalopathyUludag University
- RECRUITINGNANCT07527104Autologous Bone Marrow Mononuclear Cell Transplantation Combined With Rehabilitation in Children With Sequelae of Hypoxic-Ischemic Encephalopathy or Intracranial HemorrhageNational Children's Hospital, Vietnam
- ENROLLING BY INVITATIONPHASE1NCT06429007A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain InjuryBoston Children's Hospital
- RECRUITINGNANCT07555652Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy in VietnamNational Children's Hospital, Vietnam
- RECRUITINGNANCT06762795The HIEnome Study: Genome Sequencing for Perinatal HIEBaylor College of Medicine
- RECRUITINGNCT07136636Speech of Kids After Neonatal EncephalopathySemmelweis University
See all trials for Neonatal hypoxic and ischemic brain injury →